Acumen Pharmaceuticals, Inc. (ABOS)
NASDAQ: ABOS · Real-Time Price · USD
1.880
0.00 (0.00%)
At close: Oct 8, 2025, 4:00 PM EDT
1.860
-0.020 (-1.06%)
After-hours: Oct 8, 2025, 7:34 PM EDT

Acumen Pharmaceuticals Statistics

Total Valuation

ABOS has a market cap or net worth of $113.88 million. The enterprise value is -$21.58 million.

Market Cap113.88M
Enterprise Value -21.58M

Important Dates

The next estimated earnings date is Tuesday, November 11, 2025, before market open.

Earnings Date Nov 11, 2025
Ex-Dividend Date n/a

Share Statistics

ABOS has 60.57 million shares outstanding. The number of shares has increased by 3.87% in one year.

Current Share Class 60.57M
Shares Outstanding 60.57M
Shares Change (YoY) +3.87%
Shares Change (QoQ) +0.08%
Owned by Insiders (%) 10.92%
Owned by Institutions (%) 32.63%
Float 35.61M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 0.97
P/TBV Ratio 0.98
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 5.97, with a Debt / Equity ratio of 0.26.

Current Ratio 5.97
Quick Ratio 5.79
Debt / Equity 0.26
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -34.84

Financial Efficiency

Return on equity (ROE) is -75.71% and return on invested capital (ROIC) is -42.77%.

Return on Equity (ROE) -75.71%
Return on Assets (ROA) -39.06%
Return on Invested Capital (ROIC) -42.77%
Return on Capital Employed (ROCE) -97.92%
Revenue Per Employee n/a
Profits Per Employee -$2.24M
Employee Count61
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -21.01% in the last 52 weeks. The beta is 0.20, so ABOS's price volatility has been lower than the market average.

Beta (5Y) 0.20
52-Week Price Change -21.01%
50-Day Moving Average 1.43
200-Day Moving Average 1.33
Relative Strength Index (RSI) 68.74
Average Volume (20 Days) 420,950

Short Selling Information

The latest short interest is 1.36 million, so 2.24% of the outstanding shares have been sold short.

Short Interest 1.36M
Short Previous Month 1.41M
Short % of Shares Out 2.24%
Short % of Float 3.81%
Short Ratio (days to cover) 7.27

Income Statement

Revenue n/a
Gross Profit -124.21M
Operating Income -143.98M
Pretax Income -136.67M
Net Income -136.67M
EBITDA -143.92M
EBIT -143.98M
Earnings Per Share (EPS) -$2.27
Full Income Statement

Balance Sheet

The company has $143.37 million in cash and $30.10 million in debt, giving a net cash position of $136.07 million or $2.25 per share.

Cash & Cash Equivalents 143.37M
Total Debt 30.10M
Net Cash 136.07M
Net Cash Per Share $2.25
Equity (Book Value) 117.08M
Book Value Per Share 1.93
Working Capital 123.54M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$117.76 million and capital expenditures -$88,000, giving a free cash flow of -$117.85 million.

Operating Cash Flow -117.76M
Capital Expenditures -88,000
Free Cash Flow -117.85M
FCF Per Share -$1.95
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

ABOS does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -3.87%
Shareholder Yield -3.87%
Earnings Yield -119.38%
FCF Yield -102.94%

Analyst Forecast

The average price target for ABOS is $8.00, which is 325.53% higher than the current price. The consensus rating is "Strong Buy".

Price Target $8.00
Price Target Difference 325.53%
Analyst Consensus Strong Buy
Analyst Count 3
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1